Video: Can drugs be made for viruses that do not exist yet?

xw hhrcaxr aesd z qnhu
Credit: Dowell/Getty Images

[N]ovel coronaviruses seem to be making successful jumps to humans very roughly once per decade — and there’s no reason to think they’ll stop after this one.

Unfortunately for us, there’s only been so much cumulative progress when it comes to developing antivirals to fight coronaviruses. As closely related as the SARS, MERS, and COVID-19 viruses are, they’re distinct enough that researchers haven’t discovered a catch-all coronavirus drug. And unfortunately, the SARS and MERS epidemics simply may not have been catastrophic enough to motivate funders, governments, and drug companies to develop proactive antivirals before the next event.

“A non-virologist, if you remind them, will remember it happened,” says virologist Nat Moorman about the SARS and MERS outbreaks. “But the answer you typically hear is ‘yeah, but that wasn’t really that big of a deal,’ not realizing how close we really were to it being that big of a deal. And so, you know, the interest of the public, and at some level the interest of funders, fades over time.”

Related article:  How long are you infectious? COVID-19 patients struggle to find an answer
Follow the latest news and policy debates on agricultural biotech and biomedicine? Subscribe to our newsletter.

Moorman and his colleagues at UNC-Chapel Hill are determined to keep interest in antivirals high, no matter what course this pandemic ultimately takes. They’re tackling a line of research that could lead to much “broader-spectrum” antivirals: drugs that are effective against this coronavirus, but also the next one to appear — and, possibly, any virus at all.

Read the original post

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Nigeriacotton

Video: We can ‘finally’ grow GMOs—Nigerian farmer explains why developing countries need biotech crops

Nigerian farmer Patience Koku discusses the GMO crop trials she is conducting on her farm, and why growers can "rise ...
mag insects image superjumbo v

Disaster interrupted: Which farming system better preserves insect populations: Organic or conventional?

A three-year run of fragmentary Armageddon-like studies had primed the journalism pumps and settled the media framing about the future ...
dead bee desolate city

Are we facing an ‘Insect Apocalypse’ caused by ‘intensive, industrial’ farming and agricultural chemicals? The media say yes; Science says ‘no’

The media call it the “Insect Apocalypse”. In the past three years, the phrase has become an accepted truth of ...
breastfeeding bed x facebook x

Infographic: We know breastfeeding helps children. Now we know it helps mothers too

When a woman becomes pregnant, her risk of type 2 diabetes increases for the rest of her life, perhaps because ...
organic hillside sweet corn x

Organic v conventional using GMOs: Which is the more sustainable farming?

Many consumers spend more for organic food to avoid genetically modified products in part because they believe that “industrial agriculture” ...
benjamin franklin x

Are most GMO safety studies funded by industry?

The assertion that biotech companies do the research and the government just signs off on it is false ...
gmo corn field x

Do GMO Bt (insect-resistant) crops pose a threat to human health or the environment?

Bt is a bacterium found organically in the soil. It is extremely effective in repelling or killing target insects but ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies for tighter GMO legislation and famously puts out annual "dirty dozen" list of fruits and ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be the prime mover behind the ongoing campaign against agricultural biotechnology at Consumer Reports. He is an ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend